The Evaluation and Management of Methimazole-Induced Agranulocytosis in the Pediatric Patient: A Case Report and Review of the Literature
Hormone Research in Paediatrics · 2024
DOI: 10.1159/000536508 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Meghan E Fredette und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, Hasbro Children's Hospital, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Agranulocytosis, Methimazole, Graves Disease, Antithyroid Agents. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Agranulocytosis is a rare but serious complication of methimazole (MMI) use for Graves’ disease (GD). Treatment requires discontinuation of MMI, and the use of propylthiouracil (PTU) is also contraindicated. Few reports exist about the optimal alternative treatment regimens for the management of thyrotoxicosis in these medically complex patients in the pediatric population. Case Report: We report prolonged saturated solution of potassium iodide (SSKI) use (29 days) in a 17-year-old female with GD and MMI-induced agranulocytosis, who presented with septic shock. Her treatment course also included β-blockade, cholestyramine, and granulocyte colony stimulating factor. We performed a review of the literature on the use of SSKI in the management of thyrotoxicosis, as well as best practices from the view of endocrinology, infectious disease, hematology, surgery, and intensivists, for the evaluation and management of MMI-induced agranulocytosis.
Discussion
The management of MMI-induced agranulocytosis and associated sequelae require subspecialty input and intensive evaluation and monitoring. Alternative treatments to manage hyperthyroidism and control symptoms of thyrotoxicosis during agranulocytosis are a bridge to definitive therapy and include β-blockade, SSKI, cholestyramine, steroids, lithium, and plasmapheresis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Endocrinology, Hasbro Children's Hospital, Providence, Rhode Island, USA.
- Department of Pediatrics, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
- Division of Pediatric Endocrinology, Hasbro Children's Hospital, Providence, Rhode Island, USA, sabithas99@gmail.com.
- Department of Pediatrics, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA, sabithas99@gmail.com.
- Division of Pediatric Infectious Disease, Hasbro Children's Hospital, Providence, Rhode Island, USA.
- Division of Pediatric Hematology and Oncology, Hasbro Children's Hospital, Providence, Rhode Island, USA.
Zitieren
APA
Fredette, M. E., Sasidharan Pillai, S., Ibrahim, O., Kochhar, M., Cotton, T. M., Rogo, T. O., Scheffler, M. D., & Bauer, A. J. (2024). The Evaluation and Management of Methimazole-Induced Agranulocytosis in the Pediatric Patient: A Case Report and Review of the Literature. Hormone Research in Paediatrics. https://doi.org/10.1159/000536508
Vancouver
Fredette ME, Sasidharan Pillai S, Ibrahim O, Kochhar M, Cotton TM, Rogo TO, et al. The Evaluation and Management of Methimazole-Induced Agranulocytosis in the Pediatric Patient: A Case Report and Review of the Literature. Hormone Research in Paediatrics. 2024. doi:10.1159/000536508
BibTeX
@article{Fredette2024,
author = {Fredette, Meghan E and Sasidharan Pillai, Sabitha and Ibrahim, Osama and Kochhar, Manpreet and Cotton, Travis M and Rogo, Tanya O and Scheffler, Margaret D and Bauer, Andrew J},
title = {The Evaluation and Management of Methimazole-Induced Agranulocytosis in the Pediatric Patient: A Case Report and Review of the Literature},
journal = {Hormone Research in Paediatrics},
year = {2024},
doi = {10.1159/000536508}
}
EUVIMED